Why Is Creon So Hard to Find? [Explained for 2026]

If You Take Creon, You Already Know the Struggle

You've been there before: you hand your prescription to the pharmacy technician, wait for the text that your medication is ready, and instead get a call saying, "We don't have it in stock." If you take Creon (Pancrelipase), this frustrating experience may be all too familiar. In 2026, many patients with exocrine pancreatic insufficiency (EPI) are still struggling to find Creon on pharmacy shelves.

This article explains why Creon has been so difficult to find, what's causing the supply issues, and — most importantly — what you can do about it right now.

What Is Creon?

Creon is a prescription pancreatic enzyme replacement therapy (PERT) manufactured by AbbVie. It contains a combination of three digestive enzymes — lipase, protease, and amylase — derived from porcine (pig) pancreas tissue. These enzymes help your body break down fats, proteins, and carbohydrates when your pancreas can't produce enough on its own.

Creon is FDA-approved to treat exocrine pancreatic insufficiency (EPI) caused by:

• Cystic fibrosis
• Chronic pancreatitis
• Pancreatectomy (surgical removal of part or all of the pancreas)
• Other conditions that impair pancreatic function

It comes in delayed-release capsules in five strengths: 3,000, 6,000, 12,000, 24,000, and 36,000 lipase units. For a deeper dive into how this medication works, check out our guide on how Creon works.

Why Is Creon So Hard to Find in 2026?

There isn't one simple answer. Several factors have combined to make Creon difficult to locate at pharmacies across the country.

1. A Complex, Porcine-Based Supply Chain

Unlike most medications that are synthesized chemically, Creon is derived from pig pancreas glands. This biological sourcing creates a supply chain that's more vulnerable to disruption. Factors like animal disease outbreaks, changes in pork industry production, and the specialized processing required to extract and purify these enzymes can all slow down manufacturing. There are a limited number of facilities worldwide that can produce pharmaceutical-grade pancreatic enzymes, which creates bottlenecks.

2. Increased Demand for Pancreatic Enzyme Therapy

Awareness of exocrine pancreatic insufficiency has grown significantly in recent years. More patients are being diagnosed with EPI, particularly those with chronic pancreatitis, pancreatic cancer, and post-surgical conditions. As the number of prescriptions rises, manufacturers are working to keep pace — but demand has outstripped supply in some regions and for certain strengths.

3. Manufacturing and Quality Control Challenges

Because Creon is a biologically-derived product, it faces stricter FDA manufacturing standards than typical chemical drugs. Every batch must be tested for enzyme potency, microbial contamination, and potential viral transmission risk. If a batch fails quality testing, it can't be released to market. These rigorous standards are important for patient safety, but they can contribute to supply constraints when production hiccups occur.

4. No True Generic Alternative Exists

There is no FDA-approved generic version of Creon. While other branded Pancrelipase products exist (like Zenpep, Pancreaze, and Pertzye), they are not interchangeable generics — they are separate branded medications with their own supply chains. This means that when Creon specifically runs low, patients can't simply switch to a cheaper generic version without their doctor's involvement.

What Can You Do if You Can't Find Creon?

If your pharmacy tells you Creon is out of stock, don't panic. Here are several steps you can take:

Use Medfinder to Check Pharmacy Stock

Medfinder lets you search for Creon availability at pharmacies near you in real time. Instead of calling pharmacy after pharmacy, you can check stock from your phone or computer. This is especially helpful when certain strengths are harder to find than others.

Try Independent and Specialty Pharmacies

Large chain pharmacies often run out of high-demand specialty medications first. Independent pharmacies and specialty pharmacies may have better access to certain medications through different distribution channels. Don't overlook them — they may have the exact strength you need. For more tips, read our guide on how to find Creon in stock near you.

Ask Your Doctor About Alternative PERT Products

If Creon is consistently unavailable, your doctor may be able to prescribe a different pancreatic enzyme replacement such as Zenpep, Pancreaze, or Pertzye. These medications work similarly and treat the same condition, though the specific dosing may differ. Never switch on your own — always work with your prescriber.

Plan Ahead and Request Early Refills

If your insurance allows it, try to refill your Creon prescription a few days before you run out. This gives you a buffer in case your pharmacy needs to order it. Some patients also find it helpful to keep a backup pharmacy identified through Medfinder's stock checker so they have a plan B.

Look Into Patient Assistance Programs

If cost is also a barrier, AbbVie offers a Creon Savings Card for commercially insured patients and a Patient Assistance Foundation for uninsured or underinsured patients. Learn more in our article about how to save money on Creon.

Final Thoughts

Creon's supply challenges in 2026 are the result of a perfect storm: a biologically complex supply chain, rising demand, strict manufacturing requirements, and no generic alternatives. While these issues are frustrating, you do have options. Use tools like Medfinder to locate pharmacies with stock, talk to your doctor about alternatives if needed, and plan ahead when possible.

You depend on Creon to digest your food and absorb essential nutrients. Don't let supply issues catch you off guard — stay informed and stay proactive.